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http:WHAT THIS PAPER ADDS
The use of CTA with ﬂuoroscopy image fusion guidance for complex endovascular aortic aneurysm repair has
been evaluated. Image fusion technology proved to signiﬁcantly reduce procedure time and volume of iodinated
contrast material. A non-signiﬁcant reduction in ﬂuoroscopy time was observed. Respiration-related vessel
displacement and straightening of elongated vessel segments by stiff devices are currently the main limitations
in fusion image overlay accuracy.Objectives: To evaluate the effect of intraoperative guidance by means of live ﬂuoroscopy image fusion with
computed tomography angiography (CTA) on iodinated contrast material volume, procedure time, and
ﬂuoroscopy time in endovascular thoraco-abdominal aortic repair.
Methods: CTA with ﬂuoroscopy image fusion road-mapping was prospectively evaluated in patients with
complex aortic aneurysms who underwent fenestrated and/or branched endovascular repair (FEVAR/BEVAR).
Total iodinated contrast material volume, overall procedure time, and ﬂuoroscopy time were compared between
the fusion group (n ¼ 31) and case controls (n ¼ 31). Reasons for potential fusion image inaccuracy were
analyzed.
Results: Fusion imaging was feasible in all patients. Fusion image road-mapping was used for navigation and
positioning of the devices and catheter guidance during access to target vessels. Iodinated contrast material
volume and procedure time were signiﬁcantly lower in the fusion group than in case controls (159 mL [95% CI
132e186 mL] vs. 199 mL [95% CI 170e229 mL], p ¼ .037 and 5.2 hours [95% CI 4.5e5.9 hours] vs. 6.3 hours
(95% CI 5.4e7.2 hours), p ¼ .022). No signiﬁcant differences in ﬂuoroscopy time were observed (p ¼ .38).
Respiration-related vessel displacement, vessel elongation, and displacement by stiff devices as well as patient
movement were identiﬁed as reasons for fusion image inaccuracy.
Conclusion: Image fusion guidance provides added value in complex endovascular interventions. The technology
signiﬁcantly reduces iodinated contrast material dose and procedure time.
 2014 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
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Multimodality image fusion guidance is a new alternative to
conventional angiogram road-mapping in endovascular in-
terventions. The technology follows two principles:1 (a) to co-
register and fuse pre-acquired image datasets (e.g.
computed tomography angiography [CTA] or magnetic
resonance angiography [MRA]) with another dynamic imag-
ing modality, commonly ﬂuoroscopy; (b) to overlay real-time
catheter and guidewire movements to the pre-acquired
background dataset. Rigid co-registration is performed byrresponding author. A.M. Sailer, Department of Radiology, Maas-
University Medical Centre (MUMC), P. Debyelaan 25, 6229 HX
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//dx.doi.org/10.1016/j.ejvs.2013.12.022means of a C-arm cone beam computed tomography (CBCT)
system, allowing the pre-acquired dataset to follow any
rotation of the C-arm and table movement. Recently, fusion
image road-mapping has been evaluated for cardiologic in-
terventions and in endovascular surgery.2e6 Nevertheless,
broad application of this technique for routine practice and
evaluation of added value and limitations has yet to happen.
The purpose of this work was to evaluate the effect of real-
time ﬂuoroscopy with CTA image fusion guidance on iodin-
ated contrast material usage, procedure time, and ﬂuoros-
copy time in branched and fenestrated repair of complex
aortic aneurysms. We further aimed to analyze and quantify
limitations of fusion road-map accuracy.
MATERIALS AND METHODS
Image fusion technology was prospectively evaluated for
intraprocedural road-mapping in 31 patients with complex
350 A.M. Sailer et al.aortic aneurysms who underwent fenestrated and/or
branched endovascular repair (FEVAR/BEVAR) between
March 2012 and September 2013.The studywas approved by
the institutional ethics committee and the requirement for
informed consent was waived by the IRB. Prior to the inter-
vention, all patients had undergone outpatient diagnostic
CTA scans on a second-generation dual-source CT scanner
(Somatom Deﬁnition, Siemens Healthcare, Forchheim, Ger-
many) for measurements and planning of the custom-made
endografts. The CTA scans were carried out in dual-energy
settings, allowing for dedicated post-processing, including
automated bone removal. The endovascular procedure was
performed in our hybrid operating theater. Just before sur-
gical vascular access was obtained, an abdominal non-
contrast-enhanced CBCT was performed by rotational
movement of the C-arm covering a 180-degree circular tra-
jectory (Allura Xper FD20, Philips Healthcare, Best, The
Netherlands). Standard parameters for CBCTwere 123 kV and
additional ﬁltration of 0.9 mm of copper plus 1 mm of
aluminum. The volumetric dataset of a total of 316 images
was automatically transferred to a 3D workstation (PhilipsTable 1. Aneurysm characteristics and FEVAR/BEVAR design in the fus
Fusion group
Patient ID Type of aneurysm No. of
fenestrations (F)/
branches (B)
Bifurcated
endovascular
graft
1 TAAA I 4 B No
2 TAAA III 3 F/1 B No
3 TAAA IV 3 B No
4 Juxtarenal AAA 4 F Yes
5 TAAA I 2 F No
6 TAAA III 4 B No
7 TAAA III 4 F No
8 TAAA I 3 F/1 B Yes
9 TAAA III 6 B Yes
10 TAAA III 2 F/2 B No
11 Juxtarenal AAA 3 F Yes
12 TAAA II 4 B No
13 TAAA II 4 B Yes
14 TAAA III 4 B Yes
15 TAAA III 4 B No
16 TAAA IV 3 F Yes
17 Juxtarenal AAA 3 F Yes
18 TAAA I 4 F No
19 Juxtarenal AAA 3 F Yes
20 TAAA IV 4 F Yes
21 TAAA I 4 B No
22 TAAA IV 3 F Yes
23 TAAA III 3 F/1 B No
24 Juxtarenal AAA 3 F No
25 Iliac aneurysm 1 B Yes
26 Juxtarenal AAA 3 F Yes
27 TAAA III 3 F/1 B Yes
28 Juxtarenal AAA 1 F No
29 Juxtarenal AAA 3 F Yes
30 TAAA V 2 F/2 B No
31 TAAA III 2 F/2 B No
Total number F/B 61 F/51 B
Note. TAAA ¼ type of thoraco-abdominal aortic aneurysm according tAllura XtraVision 8.3) and co-registered to patients’ pre-
interventional diagnostic CTA images. Arterial vessel wall
calciﬁcations and bone borders were used as landmarks.
During the intervention, the fusion road-map was presented
in real-time on a screen next to conventional ﬂuoroscopy.
Fusion image road-mapping was used for navigation and
positioning of the stent graft. Before deployment, the ac-
curacy of the fusion road-map and correct position of the
stent graft were evaluated by conventional angiography. For
catheterization of fenestrations, branches and target vessel,
optimal C-arm projection angles were identiﬁed on the
fusion road-map and access was obtained using fusion
guidance. After catheterization, the correct position was
tested by catheter injection.Caseecontrols
In our clinic, more than 150 FEVAR and BEVAR procedures
have been performed since 2006. All of these procedures
were performed by the same vascular surgeon together
with the same interventional radiologist (last and secondion and caseecontrol groups.
Caseecontrol group
Patient ID Type of
aneurysm
No. of
fenestrations (F)/
branches (B)
Bifurcated
endovascular
graft
32 TAAA I 4 B No
33 TAAA IV 4 F No
34 Juxtarenal AAA 3 F No
35 TAAA IV 3 F/1 B Yes
36 TAAA I 2 F No
37 TAAA IV 4 B No
38 TAAA IV 4 F No
39 TAAA II 1F/3 B Yes
40 TAAA II 4 B Yes
41 TAAA IV 4 F No
42 Juxtarenal AAA 3 F Yes
43 TAAA II 4 B Yes
44 TAAA II 4 B Yes
45 TAAA III 1F/3 B No
46 TAAA II 4 B No
47 TAAA IV 4 B Yes
48 Juxtarenal AAA 3 F Yes
49 TAAA I 4 B No
50 Juxtarenal AAA 3 F Yes
51 TAAA IV 4 B Yes
52 TAAA I 4 B No
53 TAAA IV 3 F Yes
54 TAAA IV 4 F No
55 Juxtarenal AAA 3 F No
56 Iliac aneurysm 1 B Yes
57 Juxtarenal AAA 3 F yes
58 TAAA III 1F/3 B Yes
59 Juxtarenal AAA 2 F No
60 Juxtarenal AAA 3 F Yes
61 TAAA IV 4 F No
62 Juxtarenal AAA 2 F No
Total number F/B: 56 F/51 B
o Crawford classiﬁcation.
Figure 1. Three dimensional co-registration of volumetric pre-acquired computed tomography angiography (CTA) dataset (grey) with cone
beam computed tomography (CBCT) dataset (blue). Top row: Aortic wall calciﬁcations (white arrows) on CBCT and CTA datasets are
selected as landmarks and marked with the crosshair. Bottom row: The fused dataset is further adjusted in three dimensions by scrolling
through the dataset and aligning bone borders and other calciﬁcations (sagittal plane not shown).
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2012 and September 2013 were consecutively included in
the fusion guidance group. Due to maintenance/software
updates, the fusion technology was not available in October
2012 and between April and May 2013; procedures during
this period were included in the caseecontrol group. Cases
and controls were collected from our historical pool of
FEVAR/BEVAR procedures without fusion guidance and
limited to the period between 2010 and 2013. Cases and
controls were technically comparable in procedure
complexity expressed in type of aneurysm (type of TAAA
according to Crawford classiﬁcation, juxtarenal AAA, and
one iliac aneurysm), number of fenestrations, and branches
as well as presence or absence of a bifurcated endovascular
graft. Where more than one case control matched the
fusion case, the more recent procedure was included.
Outcome parameters
The radiation dose of CBCT in terms of doseearea product
(DAP, in mGym2) was registered. The total volume of pro-
cedural iodinated contrast material (iopromide, 300 mg/mL;Ultravist, Bayer HealthCare, Berlin) and overall procedure
time were registered and compared with data from the
caseecontrols. For the last 22 procedures, ﬂuoroscopy time
was also registered and compared with available casee
control data. Reasons for potential fusion road-map inac-
curacies were analyzed and quantiﬁed by the multidisci-
plinary team.Statistical analysis
For continuous variables, the t test for independent samples
or the Wilcoxon test was used for normally and non-
normally distributed data respectively (SPSS statistics 20.0,
Chicago, IL, USA). Two sided p < .05 were considered sig-
niﬁcant. Quantitative values are presented by means and
95% conﬁdence intervals.RESULTS
The fusion group consisted of 26 men and ﬁve women, with
a mean age of 74  6 years. The demographics of the fusion
(n ¼ 31) and caseecontrol groups (n ¼ 31) were similar. An
Figure 2. Stent graft placement based on fusion road-map after control for correct overlay position on conventional angiogram. Live
ﬂuoroscopy image with main body grafts (white) overlaid on pre-acquired computed tomography angiography background (red) in two
different patients.
352 A.M. Sailer et al.accurate caseecontrol match for every fusion patient was
retrieved on the basis of aneurysm and endograft charac-
teristics. Detailed information on aneurysm type and
endograft design for fusion and control patients is shown in
Table 1. Mean radiation dose of CBCT was 1.43 mGym2
(95% CI 1.20e1.66 mGym2). Image co-registration and
fusion guidance were feasible in all procedures. Co-
registration of the CBCT to the CTA dataset is shown in
Fig. 1. Figs. 2 and 3 demonstrate fusion guidance during the
FEVAR and BEVAR procedures.
All variables were normally distributed. The mean total
procedure time in the fusion group was 5.2 hours (95% CI
4.5e5.9 hours), which was signiﬁcantly lower than theFigure 3. Fusion image guidance for left renal artery (A) and celiac tr
guidewire (white arrows) in the left renal artery (red arrow head) and s
arteries (white arrow heads).control group (6.3 hours, 95% CI 5.4e7.2 hours, p ¼ .022).
The mean procedural iodinated contrast material dose in
the fusion group was 159 mL (95% CI 132e186 mL) versus
199 mL (95% CI 170e229 mL) in the control group. This
difference was also signiﬁcant (p ¼ .037). Concerning
ﬂuoroscopy time, complete data could be retrieved for 11
pairs of fusion and caseecontrol procedures. The average
ﬂuoroscopy time of the fusion group (50 minutes and 26
seconds, 95% CI 30:33e70:18) and caseecontrol group (59
minutes and 29 seconds, 95% CI 40:40e78:19) were not
signiﬁcantly different (p ¼ .38). Table 2 provides a detailed
overview of the objective outcome parameters of the fusion
and caseecontrol FEVAR/BEVAR procedures.unk (B) catheterization from a transbrachial approach. Tip of the
plenic artery (red arrow) respectively. Covered stents in both renal
Table 2. Iodinated contrast volume, procedure time and ﬂuoroscopy time in fusion and caseecontrol procedures.
ID Iodinated contrast volume (mL) Total procedure time (h) Fluoroscopy time (min:s)
Fusion e caseecontrol Fusion CaseeControl Fusion CaseeControl Fusion CaseeControl
1 e 32 160 NA 6 7.5
2 e 33 110 250 4.5 11
3 e 34 180 150 10 4.5
4 e 35 200 250 7.75 10.25
5 e 36 180 150 3.75 4
6 e 37 200 250 5.25 5.75
7 e 38 200 120 5.75 6
8 e 39 125 325 7 8
9 e 40 100 350 9 10
10 e 41 75 80 7 8 93:41 NA
11 e 42 100 120 6 3 NA 71:02
12 e 43 Conversion 250 Conversion 8 Conversion NA
13 e 44 150 250 7.5 8 59:58 NA
14 e 45 275 100 5 8.25 55:00 97:00
15 e 46 200 250 3 7.5 39:29 NA
16 e 47 90 220 3.25 5.5 26:42 NA
17 e 48 90 300 4.5 5 97:34 118:24
18 e 49 145 175 3.5 5 46:03 NA
19 e 50 225 150 5.25 3 81:12 57:38
20 e 51 200 270 5 5.5 42:21 58:00
21 e 52 320 250 4.5 8.5 84:29 51:00
22 e 53 120 125 4.5 6 45:41 61:39
23 e 54 200 150 7 6.25 111:13 NA
24 e 55 140 130 4.25 8 14:45 65:53
25 e 56 80 200 3.75 3.5 20:53 44:38
26 e 57 90 100 2.5 3 25:56 47:05
27 e 58 300 300 6 10.25 94:47 NA
28 e 59 100 220 3 2 16:19 38:52
29 e 60 160 300 4.5 6 70:32 14:13
30 e 61 240 150 5 6 85:47 NA
31 e 62 25 100 3 3 30:09 NA
Mean 159 199 5.2 6.3 50:26 59:29
Standard deviation 71 78 1.8 2.4 29:35 28:01
Note. Mean and standard deviation calculated only for pairs with complete data. NA ¼ data not available.
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To some extent, fusion image overlay inaccuracy was
observed during all procedures and was grouped into three
main categories.
1. Overlay inaccuracy due to differences between CTA and
CBCT acquisition.
The average time interval between acquisition of the
diagnostic CTA and acquisition of the CBCT on the
date of elective custom-made endograft repair was
approximately 3 months. No overlay inaccuracies
were observed due to these intervals. However, a
mismatch between the pre-acquired CTA images and
live ﬂuoroscopy due to respiration-related vessel
displacement was observed in all patients. In our
clinic, diagnostic CTA scans are performed during
breath-hold inspiration: a condition which is not
typical for general anesthesia with low tidal volume
ventilation. Respiration-related vessel mismatch was
mainly observed at the level of the aortic arch and
peripheral segments of the visceral branches. In Fig. 3,
the mismatch between the tip of the guidewire andthe CTA overlay road-map in a distal section of the
renal and splenic arteries is visible.2. Overlay inaccuracy due to rigid co-registration.
Straightening and deformation of the vessel tree by
stiff guidewires and stiff introduction devices was
observed in 20 cases, mainly at the level of tortuous
iliac arteries and distal elongated descending thoracic
aorta. As co-registration with the pre-acquired CTA
was performed in a rigid, non-elastic manner, any
deformation of the vessel tree resulted in non-
eradicable overlay inaccuracy during maneuver with
stiff devices. Fig. 4 visualizes vessel deformity during
graft introduction resulting in temporary overlay
inaccuracy of the non-elastic fusion road-map.3. Overlay inaccuracy due to patient movement
Any patient movement after CBCT acquisition
resulted in overlay inaccuracy to the same extent and
in the same direction as the original movement. As
patients were under general anesthesia during the
intervention, and CBCT was acquired immediately
before vascular access, inaccuracy due to patient
Figure
fusion
asteris
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repositioned by the surgical team. In the two cases,
overlay mismatch could be eradicated by manual
readjustment of the fusion road-map.Complications
A complication was observed during the procedure of pa-
tient no. 12. While achieving access to the target vessel
through the branch of the right renal artery, the guidewire
and catheter were incorrectly positioned in the right colic
artery (RCA). With the single plane C-arm in the anteriore
posterior position and radiation protection shields covering
the right ﬂank, the superposition was neither detected on
conventional angiogram nor on the fusion road-map.
Deployment of the covered stent grafts obstructed the su-
perior mesenteric artery distal to the RCA oriﬁce with the
need for surgical stent removal from the RCA and perfor-
mance an iliac-superior mesenteric artery bypass. No major
complications from the conversion have occurred. The pa-
tient has refused to undergo a second procedure connect-
ing the renal and celiac branch to their target vessels.DISCUSSION
The use of multimodality image fusion road-mapping in
routine practice of complex endovascular aortic repair was
evaluated. The data from the presented caseecontrol study
demonstrates that CTA with ﬂuoroscopy fusion technology4. Fusion road-map overlay accuracy (A) with guide wires (whit
overlay inaccuracy (B) during introduction of the stiff graft dev
ks) due to rigid image co-registration.results in signiﬁcant reduction in procedure time and
iodinated contrast material volume. A trend towards lower
procedural ﬂuoroscopy time was observed. Signiﬁcant
reduction of contrast material volume (p ¼ .001) by means
of fusion image road-mapping in complex EVAR has been
described previously by Dijkstra et al.5 and Tacher et al.6 A
single case of zero-contrast TEVAR using fusion has also
been reported.4 Fenestrated and branched stent graft
technology makes it possible to perform endovascular
repair for complex aortic disease. Conventionally performed
FEVAR/BEVAR is associated with a signiﬁcant risk of adverse
renal events due to the large volumes of contrast material
used.7,8 Any effort and technology supporting a reduction in
the volume of contrast material used is therefore highly
relevant. Fusion image road-mapping promises signiﬁcant
beneﬁts for vascular patients. However, there are some
limitations of this technology and safety aspects that need
to be discussed.
In our study, at all critical steps during the procedures,
conventional angiograms were performed to conﬁrm the
correct position of the devices. This allowed us to get
acquainted with fusion road-mapping and gain conﬁdence
with the new technology. In these procedures, contrast
injections and procedure time were mainly reduced by
more efﬁcient target vessel catheterization under fusion
road-map guidance. This provided a valuable beneﬁt re-
ﬂected in the results of our study. Nevertheless, this beneﬁt
is small compared with stent graft deployment used solely
on the basis of the fusion road-map. With growinge arrow head) precisely matching the vessel tree. Temporary local
ice (white arrow) at level of kinking elongated vessel tree (white
European Journal of Vascular and Endovascular Surgery Volume 47 Issue 4 p. 349e356 April/2014 355experience, in the last procedure, the aortograms prior to
successful main device deployment under fusion guidance
were omitted. It is however important to note that the
amount of contrast volume saved due to the omitted aor-
tograms is of trivial importance compared with the poten-
tial complication of a misplaced fenestrated device. In order
to rely fully on fusion road-mapping, practical experience
and precise knowledge of the limitations and accuracy er-
rors of this technology are of critical importance. Inaccur-
acies of the overlay road-map were observed to some
extent in all procedures, with respiration-related vessel
displacement and temporary straightening of elongated
vessels during maneuver with stiff devices being the most
frequent. However, these inaccuracies may not hamper use
of the fusion road-map provided the error and its range
become predicable. Inaccuracies in locating peripheral
segments of vessels due to organ movement corresponding
to respiration-related diaphragm movement do not limit
the use of the fusion road-map as long as the origin of the
target vessels does not change position. In the fusion road-
map accuracy analysis during EVAR from Fukuda et al.,10 the
mean error of renal artery origin overlay image was
2  2.5 mm, with a range from 0 to 7 mm. Further precise
analyses of anatomy, respiration, and related overlay error
are necessary to provide quantiﬁed predictions of overlay
accuracy and expected extent of possible displacement.
With growing experience and trust, further signiﬁcant re-
ductions of iodinated contrast volume and radiation expo-
sure is to be expected.
There are limitations due to our study design. In the
setting of advanced endovascular repair, procedure
complexity and therefore procedure time, iodinated
contrast volume and radiation dose are inﬂuenced by stent
graft complexity. A caseecontrol design with matching pairs
based on stent graft complexity was therefore chosen.
Controls were retrieved from a large pool of primarily his-
torical procedures. This implies risk of bias in control se-
lection as well as bias due to differences in operator
experience. Controls had to most accurately technically
match the fusion procedures; in the fusion group, the total
number of fenestrations was slightly higher than the control
group (Table 1). When there was more than one matching
control, controls were prioritized by procedure date and
only included procedures after 2010 aiming to minimize
effects of experience level on our results. In this clinic more
than 150 FEVAR and BEVAR procedures have been per-
formed since 2006, all carried out by the same two spe-
cialists. Assuming that the learning curve after 2010 might
already have ﬂattened, experience gain during the pro-
cedures included in this study was expected to have minor
inﬂuence on the signiﬁcance of our results. Since 2010,
there have been no changes in operation protocol and time
registration that could have inﬂuenced our results. How-
ever, prospective randomized controlled studies evaluating
fusion guidance are lacking but are needed. Furthermore, in
future studies, radiation exposure should be focused. Mul-
timodality image co-registration is possible by means of
performance of a C-arm CBCT system. With the surgicalteam usually outside the operation theater during acquisi-
tion, CBCT does not result in additional radiation exposure
for the medical staff. However, patients undergoing CBCT
are exposed to an extra load of radiation, in our study in the
range between 0.5 and 2.6 mGym2, depending on body
length and weight. The total DAP of fenestrated and
branched endovascular aneurysm repair procedures has
been described in the range of 1e78 mGym2.9 The case
control pairs were not matched for body characteristics.
Procedural DAP is inﬂuenced by patients’ body mass index
and further non-comparable between all procedures due to
a software update of our hybrid ﬂuoroscopy unit intended
to shift radiation dose to a lower level. Considering this, the
protocol was altered to compare ﬂuoroscopy time, which is
not inﬂuenced by body size and ﬂuoroscopy units ﬁlters but
indirectly reﬂects radiation exposure. Mean ﬂuoroscopy
time was on average 9 minutes lower in the fusion group.
However, complete data could only be provided for 11 pairs
for this variable. This limitation might have resulted in this
observation not reaching statistical signiﬁcance. Neverthe-
less, any reduction in ﬂuoroscopy time is still relevant as it
results in effective radiation dose reduction for the medical
staff. A signiﬁcant reduction of ﬂuoroscopy time by use of
fusion road-mapping might equalize patients’ total proce-
dural radiation exposure or even be decreased by fusion
technology. In conclusion, further research evaluating in-
ﬂuence of fusion guidance on ﬂuoroscopy time and proce-
dural radiation dose is needed.
There was one complication in the group of fusion pa-
tients. Due to superposition of vessels on the single plane
view, catheter malposition was not recognized. In this
respect, fusion road-map did not show superiority in terms
of safety compared with conventional angiography. As
volumetric CTA datasets are registered, any further
improvement of the technology to provide real-time three-
dimensional views would be beneﬁcial and could address
these actual limitations of two-dimensional fusion road-
mapping.
Technical requirements for fusion guidance are a CBCT-
feasible ﬂuoroscopy unit as well as dataset co-registration
software. Flat panel detectors that can acquire rotational
3D images, such as CBCT, have begun to replace conven-
tional ﬂuoroscopy units and co-registration software for
image fusion is commercially available from different
vendors. In our experience, time for CBCT acquisition was
approximately 5 minutes and image co-registration was
carried out while further preparations of the patient took
place. Actual time loss for fusion set up was therefore
negligible. For fusion guidance, semi-automated or auto-
mated removal of bones and other radiodense non-
vascular structures should be performed on CTA data-
sets to avoid over-projection on the vessel tree overlay
image.
In conclusion, fusion image guidance provided added
value for FEVAR/BEVAR procedures in terms of procedure
time and contrast volume reduction. Further application of
this new technology to less complex but high volume
routine procedures, for example peripheral artery
356 A.M. Sailer et al.interventions might alter experience and further enhance
procedural safety, for patients and surgeons.
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